Anthony T. Reder to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Anthony T. Reder has written about Randomized Controlled Trials as Topic.
Connection Strength
0.715
-
Response to GS Gronseth and E Ashman. Mult Scler. 2012 Nov; 18(11):1661-2; author reply 1663-4.
Score: 0.328
-
Evidence-based medicine: promise and pitfalls. Mult Scler. 2012 Jul; 18(7):947-8.
Score: 0.321
-
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. Mult Scler. 2019 05; 25(6):837-847.
Score: 0.030
-
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS. PLoS One. 2011; 6(11):e22444.
Score: 0.019
-
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study. Clin Ther. 2009 Aug; 31(8):1724-36.
Score: 0.016